322 related articles for article (PubMed ID: 18548743)
1. Eight new bispyridinium oximes in comparison with the conventional oximes pralidoxime and obidoxime: in vivo efficacy to protect from diisopropylfluorophosphate toxicity.
Lorke DE; Nurulain SM; Hasan MY; Kuca K; Musilek K; Petroianu GA
J Appl Toxicol; 2008 Oct; 28(7):920-8. PubMed ID: 18548743
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of two new asymmetric bispyridinium oximes (K-27 and K-48) in rats exposed to diisopropylfluorophosphate: comparison with pralidoxime, obidoxime, trimedoxime, methoxime, and HI-6.
Lorke DE; Hasan MY; Nurulain SM; Kuca K; Schmitt A; Petroianu GA
Toxicol Mech Methods; 2009 May; 19(4):327-33. PubMed ID: 19778224
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of eight experimental bispyridinium oximes against paraoxon-induced mortality: comparison with the conventional oximes pralidoxime and obidoxime.
Nurulain SM; Lorke DE; Hasan MY; Shafiullah M; Kuca K; Musilek K; Petroianu GA
Neurotox Res; 2009 Jul; 16(1):60-7. PubMed ID: 19526299
[TBL] [Abstract][Full Text] [Related]
4. In vitro oxime protection of human red blood cell acetylcholinesterase inhibited by diisopropyl-fluorophosphate.
Lorke DE; Hasan MY; Arafat K; Kuca K; Musilek K; Schmitt A; Petroianu GA
J Appl Toxicol; 2008 May; 28(4):422-9. PubMed ID: 18344198
[TBL] [Abstract][Full Text] [Related]
5. Minireview: does in-vitro testing of oximes help predict their in-vivo action after paraoxon exposure?
Lorke DE; Petroianu GA
J Appl Toxicol; 2009 Aug; 29(6):459-69. PubMed ID: 19603416
[TBL] [Abstract][Full Text] [Related]
6. Five oximes (K-27, K-48, obidoxime, HI-6 and trimedoxime) in comparison with pralidoxime: survival in rats exposed to methyl-paraoxon.
Petroianu GA; Nurulain SM; Nagelkerke N; Shafiullah M; Kassa J; Kuca K
J Appl Toxicol; 2007; 27(5):453-7. PubMed ID: 17304644
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K
Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
[TBL] [Abstract][Full Text] [Related]
8. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: survival in rats exposed to the organophosphate paraoxon.
Petroianu GA; Nurulain SM; Nagelkerke N; Al-Sultan MA; Kuca K; Kassa J
J Appl Toxicol; 2006; 26(3):262-8. PubMed ID: 16583462
[TBL] [Abstract][Full Text] [Related]
9. In vitro oxime reactivation of red blood cell acetylcholinesterase inhibited by methyl-paraoxon.
Petroianu GA; Arafat K; Nurulain SM; Kuca K; Kassa J
J Appl Toxicol; 2007; 27(2):168-75. PubMed ID: 17265452
[TBL] [Abstract][Full Text] [Related]
10. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibited by paraoxon.
Petroianu GA; Arafat K; Kuca K; Kassa J
J Appl Toxicol; 2006; 26(1):64-71. PubMed ID: 16193529
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment for acute exposure to diisopropylfluorophosphate: in vivo efficacy of various acetylcholinesterase inhibitors.
Lorke DE; Hasan MY; Nurulain SM; Shafiullah M; Kuča K; Petroianu GA
J Appl Toxicol; 2011 Aug; 31(6):515-23. PubMed ID: 20981864
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods.
Kuca K; Cabal J; Kassa J
Pharmazie; 2004 Oct; 59(10):795-8. PubMed ID: 15544060
[TBL] [Abstract][Full Text] [Related]
13. Oximes as pretreatment before acute exposure to paraoxon.
Lorke DE; Nurulain SM; Hasan MY; Kuča K; Petroianu GA
J Appl Toxicol; 2019 Nov; 39(11):1506-1515. PubMed ID: 31264735
[TBL] [Abstract][Full Text] [Related]
14. Acetylcholinesterase inhibition: does it explain the toxicity of organophosphorus compounds?
Maxwell DM; Brecht KM; Koplovitz I; Sweeney RE
Arch Toxicol; 2006 Nov; 80(11):756-60. PubMed ID: 16770629
[TBL] [Abstract][Full Text] [Related]
15. Bispyridinium oximes as antidotal treatment of cyclosarin poisoning-in vitro and in vivo testing.
Bartosova L; Kuca K; Jun D; Kunesova G
Int J Toxicol; 2005; 24(6):399-402. PubMed ID: 16393932
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of the reactivating effect of BI-6, a new asymmetrical bispyridinium oxime, with oxime HI-6 and obidoxime on soman-inhibited acetylcholinesterase in the diaphragm and various parts of the brain in rats].
Kassa J; Bajgar J
Cas Lek Cesk; 1999 Aug; 138(17):532-5. PubMed ID: 10566233
[TBL] [Abstract][Full Text] [Related]
17. Effect of different oximes on rat and human cholinesterases inhibited by methamidophos: a comparative in vitro and in silico study.
Lugokenski TH; Gubert P; Bueno DC; Nogara PA; de Aquino Saraiva R; Barcelos RP; Carratu VS; Bresolin L; de Vargas Barbosa NB; Pereira ME; da Rocha JB; Soares FA
Basic Clin Pharmacol Toxicol; 2012 Dec; 111(6):362-70. PubMed ID: 22703537
[TBL] [Abstract][Full Text] [Related]
18. Hydrolysis of an acetylthiocholine by pralidoxime iodide (2-PAM).
Sakurada K; Ikegaya H; Ohta H; Akutsu T; Takatori T
Toxicol Lett; 2006 Oct; 166(3):255-60. PubMed ID: 16971069
[TBL] [Abstract][Full Text] [Related]
19. Comparison of in vitro potency of oximes (pralidoxime, obidoxime, HI-6) to reactivate sarin-inhibited acetylcholinesterase in various parts of pig brain.
Kuca K; Cabal J; Kassa J; Jun D; Hrabinová M
J Appl Toxicol; 2005; 25(4):271-6. PubMed ID: 16021679
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K; Bajgar J
Clin Toxicol (Phila); 2009 Jan; 47(1):72-6. PubMed ID: 18686075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
